Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Hanmi Science Co Ltd (Hanmi Science) is a healthcare company that researches and develops pharmaceutical products. The company offers health functional food products for liver, bone and joint care, eye health, gut and intestines, and blood circulation conditions. Hanmi Science offers medical devices that comprise nasal packing agents, goal replacement systems, soft tissue adhesives, anti-adhesion agents, styptics and diagnostic tools. The company also offers cosmetics and skincare products. It markets its products under the brands RESORBA, Q-Guard, Epistax, LIQUIBAND and KOLLAGEN resorb, among others. The company operates in the UK, South Korea, Japan, and China. Hanmi Science is headquartered in Hwaseong-Si, Gyeonggi-Do, South Korea.
Headquarters
South Korea
Address
Paltan Industrial Complex, 214, Muha-Ro, Paltan-Myeon, Hwaseong, 18536
Website
hanmiscience.co.kr
Telephone
82 2 4109114
No of Employees
489
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
008930 (KRX)
Revenue (2024)
$955.0M
5.7%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
99.2%
(2024 vs 2023)
Market Cap*
$2.6B
Net Profit Margin (2024)
XYZ
88.3%
(2024 vs 2023)
* As of and is in US$
Hanmi Science Co Ltd premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Healthcare Functional Products | RESORBA |
| Soy Milk | Q-Guard |
| General Food Products | Epistax |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Contracts/Agreements | In August, Hanmi Pharm signed an exclusive licensing agreement with Genentech to develop, manufacture, and commercialize Hanmi’s novel metabolic treatment candidate, HM17321 (UCN2), for obesity and associated conditions. |
| 2026 | New Products/Services | In August, the company introduced the Berry Pearl Bakuchiol Neo Cream under the derma cosmetic brand ADESII. |
| 2026 | Contracts/Agreements | In July, the company entered into an agreement to sell its minority stake to Shin Dong-kook. |
Competitor Comparison
| Key Parameters | Hanmi Science Co Ltd | Chong Kun Dang Pharmaceutical Corp. | Daewoong Pharmaceutical Co Ltd | Dong-A Socio Holdings Co Ltd | JW Holdings Corp |
|---|---|---|---|---|---|
| Headquarters | South Korea | South Korea | South Korea | South Korea | South Korea |
| City | Hwaseong | Seoul | Hwaseong | Seoul | Gwacheon |
| State/Province | - | Seoul | - | - | - |
| No. of Employees | 489 | 1,904 | 1,742 | 273 | 128 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Choi Hyun Man | Chairman | Executive Board | 2025 | - |
| Im Joo Hyun | Vice Chairman | Executive Board | 2025 | - |
| Kim Jae kyo | Chief Executive Officer; Vice Chairman | Executive Board | 2025 | - |
| Sim Byeong Hwa | Chief Financial Officer; Vice President; Director | Executive Board | 2025 | - |
| Shin Yong Sam | Director | Non Executive Board | 2025 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer